Adam J Olszewski

Summary

Affiliation: Brown University
Country: USA

Publications

  1. pmc Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic anemia
    Yazan Migdady
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI, United States of America
    Clin Med Insights Oncol 5:343-8. 2011
  2. ncbi request reprint Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI, USA
    Ann Hematol 93:449-58. 2014
  3. doi request reprint Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
    Adam J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, Rhode Island Electronic address
    Int J Radiat Oncol Biol Phys 88:642-9. 2014
  4. pmc Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database
    A J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Ann Oncol 24:1352-9. 2013
  5. doi request reprint Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
    Breast Cancer Res Treat 138:215-23. 2013
  6. doi request reprint Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database
    Adam J Olszewski
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Cancer 119:629-38. 2013
  7. doi request reprint Survival outcomes with and without splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
    Am J Hematol 87:E119-22. 2012
  8. ncbi request reprint Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: application and outcomes
    Yazan Migdady
    The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA The Cancer Center at Memorial Hospital of Rhode Island, 111 Brewster St, Pawtucket, RI 02860, USA
    Breast 22:793-8. 2013
  9. doi request reprint Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database
    Jorge J Castillo
    Division of Hematology and Oncology, Alpert Medical School of Brown University, Rhode Island Hospital The Miriam Hospital, Providence, Rhode Island
    Cancer 119:3672-9. 2013
  10. ncbi request reprint Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis
    Kenneth D Bishop
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI Division of Hematology Oncology, Rhode Island Hospital, Providence, RI
    Int J Cancer 134:2961-71. 2014

Collaborators

Detail Information

Publications11

  1. pmc Paroxysmal nocturnal hemoglobinuria presenting with a left intraventricular thrombus in a patient with prior thymoma and aplastic anemia
    Yazan Migdady
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI, United States of America
    Clin Med Insights Oncol 5:343-8. 2011
    ..The literature regarding the interplay between autoimmunity and immunosuppression, aplastic anemia, thymoma and the emergence of PNH is reviewed...
  2. ncbi request reprint Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI, USA
    Ann Hematol 93:449-58. 2014
    ..Single-agent rituximab may offer the most favorable risk/benefit ratio in this population. ..
  3. doi request reprint Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
    Adam J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, Rhode Island Electronic address
    Int J Radiat Oncol Biol Phys 88:642-9. 2014
    ..To determine the factors associated with the use of radiation therapy and associated survival outcomes in early-stage marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT)...
  4. pmc Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database
    A J Olszewski
    The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Ann Oncol 24:1352-9. 2013
    ..Therapy for gastric marginal zone (MALT) lymphoma is largely based on single-arm trials. This observational study compared survival with radiotherapy, rituximab and combination chemoimmunotherapy in this disease...
  5. doi request reprint Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study
    Adam J Olszewski
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
    Breast Cancer Res Treat 138:215-23. 2013
    ..While limited by the small number of events, our analysis does not support the increasingly prevalent practice of administering adjuvant chemotherapy in this population without more accurate prognostic and predictive factors...
  6. doi request reprint Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database
    Adam J Olszewski
    Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Cancer 119:629-38. 2013
    ..The prognosis of patients with MALT lymphoma varies according to the anatomical site of origin...
  7. doi request reprint Survival outcomes with and without splenectomy in splenic marginal zone lymphoma
    Adam J Olszewski
    Division of Hematology Oncology, Memorial Hospital of Rhode Island, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
    Am J Hematol 87:E119-22. 2012
    ..66)or overall survival was detectable. The results strengthen the notion that, with the availability of safe and effective alternatives, splenectomy should no longer be considered the treatment of choice in SMZL...
  8. ncbi request reprint Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: application and outcomes
    Yazan Migdady
    The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA The Cancer Center at Memorial Hospital of Rhode Island, 111 Brewster St, Pawtucket, RI 02860, USA
    Breast 22:793-8. 2013
    ..In a univariate analysis administration of adjuvant chemotherapy was not associated with a significantly better recurrence rate (P = 0.33)...
  9. doi request reprint Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database
    Jorge J Castillo
    Division of Hematology and Oncology, Alpert Medical School of Brown University, Rhode Island Hospital The Miriam Hospital, Providence, Rhode Island
    Cancer 119:3672-9. 2013
    ..This study evaluated prognostic factors for survival in adult patients with BL and a potential outcome improvement over the past decade in a population-based cohort...
  10. ncbi request reprint Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis
    Kenneth D Bishop
    Department of Medicine, Alpert Medical School of Brown University, Providence, RI Division of Hematology Oncology, Rhode Island Hospital, Providence, RI
    Int J Cancer 134:2961-71. 2014
    ..Because of poor outcomes in MM, studies of systemic therapy are warranted regardless of the extent of disease at presentation. ..
  11. ncbi request reprint Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study
    Shihab Ali
    Alpert Medical School of Brown University, Providence, RI, USA
    Leuk Lymphoma 55:1570-7. 2014
    ..In conclusion, the histologic classification retains a significant prognostic value in HL and the disparities between the subtypes warrant customized treatment and surveillance strategies. ..